In June 2005, employing close to 100 people, Devgen raised more than 33 million euro in a successful IPO on Euronext Brussels.[9] Also in 2005, it established rice breeding stations in Kenya; it completed its first field trials there in 2006.[10] In 2005 it also launched field trials of its nematicide in Europe.[11]